Cerebrospinal fluid lysozyme activity in patients with central nervous system tumours.
The presence of lysozyme in the CSF is considered with regard to its value in the early diagnosis of primary or secondary CNS Tumours. Since the appearance of this enzyme in the CSF is secondary to the increase of protein in the fluid, the search for lysozyme in the CSF is of no practical help in the diagnosis of CNS tumours.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000201:enzymology; D002493:Central Nervous System Diseases / Q000134:cerebrospinal fluid / Q000201:enzymology*; D002552:Cerebral Ventricles; D002648:Child; D002675:Child, Preschool; D003397:Craniopharyngioma / Q000201:enzymology; D003560:Cysts / Q000201:enzymology; D005260:Female; D005910:Glioma / Q000201:enzymology; D006801:Humans; D006849:Hydrocephalus / Q000201:enzymology; D007223:Infant; D008297:Male; D008579:Meningioma / Q000201:enzymology; D008581:Meningitis / Q000201:enzymology; D008875:Middle Aged; D009113:Muramidase / Q000134:cerebrospinal fluid*; D009362:Neoplasm Metastasis; D009442:Neurilemmoma / Q000201:enzymology; D009447:Neuroblastoma / Q000201:enzymology; D010524:Peripheral Nervous System Neoplasms / Q000201:enzymology; D013997:Time Factors; D000159:Vestibulocochlear Nerve
D009113:Muramidase